Stocktoria
Olema Pharmaceuticals, Inc. OLMA
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2020-11-19
Olema Pharmaceuticals, Inc. statistics & valuation
Market cap$994.9M
P / B2.1×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -30.5% | -28.7% | -34.9% | -48.6% | -24.0% |
| Return on equity | -33.9% | -31.7% | -38.1% | -53.0% | -25.0% |
| Current ratio | 9.95 | 10.50 | 12.33 | 12.62 | 32.23 |
Source: SEC EDGAR filings · CIK 0001750284 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.